We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$188B
AUM Growth
+$6.54B
(+3.6%)
Cap. Flow
-$6.74B
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
4,804
New
439
Increased
1,801
Reduced
1,889
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$387M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$183M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$144M |
| 4 |
Zai Lab
ZLAB
|
+$123M |
| 5 |
Halliburton
HAL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$832M |
| 2 |
Alibaba
BABA
|
+$374M |
| 3 |
Microsoft
MSFT
|
+$321M |
| 4 |
Apple
AAPL
|
+$273M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 10.34% |
| 3 | Financials | 8.3% |
| 4 | Consumer Discretionary | 7.2% |
| 5 | Communication Services | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Compass
COMP
$8.97B
| $187K | ﹤0.01% |
+20,592
| New | +$225K |
|
|
KRON
4152
DELISTED
Kronos Bio
KRON
| $187K | ﹤0.01% |
13,730
-23,529
| -63% | -$368K |
|
4153
Cellebrite
CLBT
$3.94B
| $183K | ﹤0.01% |
+22,774
| New | +$215K |
|
|
BDSI
4154
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $183K | ﹤0.01% |
59,152
-6,225
| -10% | -$20.9K |
|
4155
CEL-SCI Corp
CVM
$23.8M
| $182K | ﹤0.01% |
851
+36
| +4% | +$11K |
|
4156
EverQuote
EVER
$844M
| $182K | ﹤0.01% |
11,648
+1,425
| +14% | +$21.7K |
|
4157
CALL
Nektar Therapeutics
NKTR
$2.46B
| $181K | ﹤0.01% |
+893
| New | +$194K |
|
4158
CALL
FuboTV Inc
FUBO
$281M
| $180K | ﹤0.01% |
967
-8,550
| -90% | -$2.4M |
|
4159
PUT
HCA Healthcare
HCA
$86.8B
| $180K | ﹤0.01% |
700
-6,800
| -91% | -$1.66M |
|
|
CURO
4160
DELISTED
CURO Group Holdings Corp.
CURO
| $178K | ﹤0.01% |
+11,121
| New | +$193K |
|
|
GBIO
4161
DELISTED
Generation Bio
GBIO
| $177K | ﹤0.01% |
2,495
+84
| +3% | +$14.7K |
|
|
EPIX
4162
DELISTED
ESSA Pharma
EPIX
| $176K | ﹤0.01% |
12,373
-1,340
| -10% | -$14.9K |
|
4163
Golar LNG
GLNG
$5.03B
| $174K | ﹤0.01% |
+14,064
| New | +$179K |
|
4164
Energous
WATT
$98.2M
| $174K | ﹤0.01% |
232
-156
| -40% | -$161K |
|
|
ZEPP
4165
Zepp Health
ZEPP
$66.3M
| $173K | ﹤0.01% |
8,565
-7,428
| -46% | -$223K |
|
|
APPH
4166
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $173K | ﹤0.01% |
44,489
-47,549
| -52% | -$254K |
|
4167
Atea Pharmaceuticals
AVIR
$376M
| $172K | ﹤0.01% |
19,261
+1,863
| +11% | +$29K |
|
4168
BlackRock MuniYield New York Quality Fund
MYN
$375M
| $172K | ﹤0.01% |
12,200
| – | – |
|
4169
Taysha Gene Therapies
TSHA
$1.78B
| $172K | ﹤0.01% |
14,756
+1,304
| +10% | +$19.7K |
|
4170
Companhia Siderúrgica Nacional
SID
$1.24B
| $171K | ﹤0.01% |
38,464
| – | – |
|
|
WEBR
4171
DELISTED
Weber Inc.
WEBR
| $171K | ﹤0.01% |
+13,160
| New | +$195K |
|
|
DOYU
4172
DouYu International Holdings
DOYU
$143M
| $169K | ﹤0.01% |
6,428
+4,365
| +212% | +$133K |
|
|
NEWP
4173
New Pacific Metals
NEWP
$970M
| $169K | ﹤0.01% |
45,238
-10,799
| -19% | -$35.2K |
|
|
PROC
4174
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
| $169K | ﹤0.01% |
+17,309
| New | +$169K |
|
|
SHLX
4175
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $169K | ﹤0.01% |
14,655
-1,000
| -6% | -$11.8K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2021 Portfolio in Review
As of Q4 2021, Credit Suisse held 4,804 positions worth $188B, up 3.6% from $182B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $6.74B in Q4 2021, closing 333 positions and reducing 1,889 holdings. Its most notable exit was Kansas City Southern, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Bank of America Series L worth $48.1M.
- Credit Suisse's largest Q4 2021 buy was Bank of America Series L: 33,252 shares worth $48.1M.
- Credit Suisse added most to Linde in Q4 2021, an estimated $387M increase.
- Credit Suisse's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $832M.
- Credit Suisse fully exited Kansas City Southern in Q4 2021, selling an estimated $126M.
- Credit Suisse's ten largest holdings make up 17% of its $188B portfolio in Q4 2021.
- Credit Suisse opened 439 new positions and closed 333 in Q4 2021.
- Credit Suisse's portfolio value rose 3.6% quarter-over-quarter to $188B.
Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.